Endo Yuta, Soeda Shu, Yoshimoto Yuki, Todate Yukitoshi, Hashimoto Tatsuru, Furukawa Shigenori, Teranishi Yasushi, Fujimori Keiya
Department of Gynecology, Southern Tohoku General Hospital, 7-115 Yatsuyamada, Koriyama, Fukushima 963-8563, Japan.
Department of Reginal Gynecologic Oncology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, Fukushima 960-1295, Japan.
J Surg Case Rep. 2024 Jul 11;2024(7):rjae452. doi: 10.1093/jscr/rjae452. eCollection 2024 Jul.
Stage IVA cervical cancer is a tumor that invades the mucosa of the bladder or rectum without distant metastasis and is difficult to treat, and concurrent chemoradiotherapy is recommended. Although radical surgery following neoadjuvant chemotherapy is a treatment option for stage IVA cervical cancer, the evidence is limited. A 51-year-old woman with bulky cervical cancer and rectal invasion was referred to our hospital. Paclitaxel and cisplatin were administered as neoadjuvant chemotherapies. After two cycles of chemotherapy, the tumor size decreased markedly. Total pelvic exenteration was performed, and a complete resection was achieved. Four cycles of paclitaxel and cisplatin were administered postoperatively. Thirty-three months after the completion of adjuvant chemotherapy, the patient was alive and free of disease. Radical surgery after neoadjuvant chemotherapy may be a treatment option for stage IVA cervical cancer with bulky tumors.
IVA期宫颈癌是一种侵犯膀胱或直肠黏膜但无远处转移的肿瘤,治疗困难,推荐同步放化疗。虽然新辅助化疗后行根治性手术是IVA期宫颈癌的一种治疗选择,但证据有限。一名51岁患有巨大宫颈癌并侵犯直肠的女性被转诊至我院。给予紫杉醇和顺铂作为新辅助化疗。两个周期化疗后,肿瘤大小明显缩小。进行了全盆腔脏器切除术,并实现了完整切除。术后给予四个周期的紫杉醇和顺铂化疗。辅助化疗完成33个月后,患者存活且无疾病。新辅助化疗后行根治性手术可能是IVA期巨大肿瘤宫颈癌的一种治疗选择。